article thumbnail

Disaster preparedness, What we have learned from COVID 19 pandemic [COVID-19]

Annals of Family Medicine

Context: Despite a joint recommendation in 2003 by the AAMC and CDC that bioterrorism and mass-casualty training be included in the medical school curriculum, few medical schools have incorporated formal disaster training. Regarding clinical education changes since March 2020, 47% (n=16) were satisfied.

article thumbnail

Cancer Doesn't Discriminate. or Does It? Dr. Rebecca Redman

Louisville Lectures

After, she examines the role of clinical trials in challenging status quo. She graduated from the University of Wisconsin School of Medicine & Public Health in 2003. Dr. Redman is affiliated with University Of Louisville Hospital and Robley Rex VA Medical Center. Learn more here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Episode 176: Antiracism in Medicine Series – Episode 8 – Towards Justice and Race Conscious Medicine

The Clinical Problem Solvers

The answer to this question may not be easily answered and may not always be found in the clinical setting. The use of race is based on a false/biological concept of race AND many studies show that this can harm patients ( i.e. clinical resources are withheld based on results of algorithm).

article thumbnail

Transition Plans for Covid-19 Products are Amongst CDRH FY2023 Priorities

FDA Law Blog

By Véronique Li, Senior Medical Device Regulation Expert & Philip Won — Last week, our blog post advised planning a transition strategy in advance of the news of the termination of the Covid-19 public health emergency. The 2013 guidance documents include, but are not limited to, in vitro diagnostic and clinical trial considerations.

Medical 52
article thumbnail

To List or Not to List; That is the Question – The FTC Signals the Potential for Greater Scrutiny of Patent Information Submissions to FDA

FDA Law Blog

The closest FDA has come is in a 2003 preamble noting that patents that claim finished dosage forms—which can include “metered aerosols, capsules, metered sprays, gels, and pre-filled drug delivery systems”—should be listed in the Orange Book, suggesting that a patent that claims both the drug substance and the delivery device should be listed.

article thumbnail

PEMPix 2023 Online Case 3: The Only Thing We Have to Fear

PEMBlog

No medication exposures. Clinical features of neonatal toxic shock syndrome-like exanthematous disease emerging in Japan. The rash had since evolved into full-body erythroderma sparing the palmar and plantar surfaces. He continued to have normal wet diapers and green-seedy stools without blood or mucus. Mom was GBS negative.

article thumbnail

Lead, follow or get out of the way

Physician's Practice

Reynolds Blog Article Innovative medical practices thrive by embracing change, prioritizing patient care and learning from setbacks to enhance success and satisfaction. For example, practices have adopted electronic medical records (EMR) systems only to find that productivity in the practice ground to a halt.